Palmatine as an Agent Against Metabolic Syndrome and Its Related Complications: A Review

Drug Des Devel Ther. 2020 Nov 17:14:4963-4974. doi: 10.2147/DDDT.S280520. eCollection 2020.

Abstract

Palmatine is a naturally occurring isoquinoline alkaloid with various pharmacological properties. Given its antioxidant and anti-inflammatory properties, palmatine may be able to impede the effects of metabolic syndrome (MetS) and its related diseases triggered by inflammation and oxidative stress. This review summarises the existing literature about the effects of palmatine supplementation on MetS and its complications. The evidence shows that palmatine could protect against MetS, and cardiovascular diseases, osteoporosis and osteoarthritis, which might be associated with MetS. These protective effects are mediated by the antioxidant and anti-inflammatory properties of palmatine. Although preclinical experiments have demonstrated the efficacy of palmatine against MetS and its related diseases, no human clinical trials have been performed to validate these effects. This research gap should be bridged to validate the efficacy and safety of palmatine supplementation in protecting humans against MetS and its related diseases.

Keywords: anti-inflammation; antioxidant; myocardial reperfusion injury; obesity; osteoarthritis; osteoporosis.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / pharmacology*
  • Antioxidants / adverse effects
  • Antioxidants / pharmacology*
  • Berberine Alkaloids / adverse effects
  • Berberine Alkaloids / pharmacology*
  • Humans
  • Inflammation / drug therapy*
  • Inflammation / metabolism
  • Metabolic Syndrome / drug therapy*
  • Metabolic Syndrome / metabolism
  • Oxidative Stress / drug effects

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Berberine Alkaloids
  • palmatine